Merck Co. sued over Gardasil HPV vaccine deceit
(Natural News) Attorneys for Baum Hedlund and co-counsel Robert F. Kennedy have filed a lawsuit against New Jersey-based Merck & Co. for knowingly hiding the fact that its Gardasil HPV vaccine can cause multiple autoimmune diseases. The lawsuit has been filed on behalf of Hayden Shain in the Superior Court of the State of California,... (Source: NaturalNews.com)
Source: NaturalNews.com - October 8, 2021 Category: Consumer Health News Source Type: news

MSD Pharmaceuticals launches gender-neutral HPV vaccine GARDASIL 9 in India
"Launching GARDASIL 9 is a crucial step towards advancing the mission of building a healthy young India by reducing the disease burden of HPV-related cancers and disease in the country," MSD India Region Managing Director Rehan A Khan said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2021 Category: Pharmaceuticals Source Type: news

Adults need to take seriously vaccines for other diseases besides covid-19 and flu
Thousands of them get sick annually from illnesses — such as pertussis, shingles, human papillomavirus and pneumonia — that could have been prevented by vaccination. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 6, 2021 Category: Consumer Health News Authors: Marlene Cimons Source Type: news

Teen Vaccine Coverage Mainly Remained Stable in 2020
FRIDAY, Sept. 3, 2021 -- In 2020, adolescent coverage with recommended vaccines remained stable, with increased coverage for human papillomavirus (HPV) vaccine, according to research published in the Sept. 3 issue of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 3, 2021 Category: Pharmaceuticals Source Type: news

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020
This report describes adolescent vaccination coverage in 2020. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 2, 2021 Category: American Health Tags: Adolescent Health HPV Vaccination (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Tetanus Vaccination Vaccines Source Type: news

Prevalence of High-Risk HPV Types Dwindled Since Vaccine Approval Prevalence of High-Risk HPV Types Dwindled Since Vaccine Approval
The human papillomavirus (HPV) vaccine has substantially reduced the prevalence of the most common high-risk HPV types, even though, in a surprise, overall HPV prevalence increased over time.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2021 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

HPV vaccine has a significant impact even if all girls and boys are not vaccinated
(Tampere University) Human papillomavirus (HPV) vaccines applied in national vaccination programs protect against most cancers associated with oncogenic, high-risk (hr) HPV types. Two recent studies demonstrate the impact of gender-neutral HPV vaccination in the overall protection against hrHPV infections already with low vaccination coverage. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2021 Category: Cancer & Oncology Source Type: news

Quickstats: Percentage of Adults Aged 18-26 Years Who Ever Received a Human Papillomavirus Vaccine, by Race and Hispanic Origin and Sex - National Health Interview Survey, United States, 2019
This report describes the percentage of adults aged 18-26 years who received a human papillomavirus vaccine, by race and Hispanic origin and sex. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 27, 2021 Category: American Health Tags: Adult Vaccinations HPV Infection (Human Papillomavirus) HPV Vaccination (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Source Type: news

To Beat Covid, Beat HIV, & Beat Inequality, Find the Money
A woman is vaccinated against COVID-19 in the indigenous community of Concordia, Colombia. Meanwhile, UN Secretary-General Antonio Guterres repeated his call for the G20 to establish a Task Force “able to deal with the pharmaceutical companies and other key stakeholders”, which would address equitable vaccine distribution through the COVAX global initiative. Credit: WHO/Nadege MazarsBy Winnie ByanyimaGENEVA, May 27 2021 (IPS) In this time of intersecting crises – the Covid crisis, the HIV crisis, the inequality crisis, and more – progress on all these crises is being blocked by another crisis: finan...
Source: IPS Inter Press Service - Health - May 27, 2021 Category: International Medicine & Public Health Authors: Winnie Byanyima Tags: Aid Development & Aid Featured Global Headlines Health Human Rights Humanitarian Emergencies Population Poverty & SDGs TerraViva United Nations Source Type: news

UVA Cancer Center, other top US cancer centers urge cancer-preventing HPV vaccinations
(University of Virginia Health System) UVA Cancer Center is joining 70 other National Cancer Institute (NCI)-designated cancer centers and partner organizations in urging physicians, parents and young adults to get cancer-preventing human papillomavirus (HPV) vaccinations back on track. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2021 Category: International Medicine & Public Health Source Type: news

HPV vaccine shows success in gay, bisexual men
(Monash University) A study by Monash University and Alfred Health found a 70 per cent reduction in one type of human papillomavirus (HPV) in gay and bisexual men after the implementation of the school-based HPV vaccination program. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 25, 2021 Category: International Medicine & Public Health Source Type: news

Sanford Burnham Prebys and other top US cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
(Sanford Burnham Prebys Medical Discovery Institute) Sanford Burnham Prebys has joined doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations to issue a joint statement urging the nation's physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 20, 2021 Category: Cancer & Oncology Source Type: news

HPV Vaccination Is Lowering U.S. Cervical Cancer Rates
WEDNESDAY, May 19, 2021 -- In a finding that offers the first evidence that the human papillomavirus (HPV) vaccine is indeed protecting women from cervical cancer, new research shows cases in the United States have slowly but steadily declined over... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 19, 2021 Category: General Medicine Source Type: news

HPV Vaccination Rates Low for Young Adults
THURSDAY, May 6, 2021 -- Self-reported human papillomavirus (HPV) vaccination rates for young adults, whether for receipt of a dose at any age or between ages 18 and 21 years, are low, although they increased from 2010 to 2018, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 6, 2021 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rates Suboptimal Within Ages 9 to 12 Years
TUESDAY, May 4, 2021 -- Despite increases since 2008, human papillomavirus (HPV) vaccination rates are suboptimal within ages 9 to 12 years, according to a study published online May 3 in Pediatrics. Onyema Greg Chido-Amajuoyi, M.B.B.S., M.P.H.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2021 Category: Pharmaceuticals Source Type: news

Too Few Young Men Have Gotten the HPV Vaccine
FRIDAY, April 30, 2021 -- The HPV vaccine isn't reaching enough young American men, researchers report. The vaccine protects against reproductive warts as well as cancers caused by human papillomavirus (HPV), the most common sexually transmitted... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 30, 2021 Category: General Medicine Source Type: news

Merck’s Gardasil vaccine crippled a 14-year-old girl who fought through the injuries, graduated and became a teacher
(Natural News) Robert F. Kennedy Jr. and the Baum Hedlund Law Firm from Los Angeles, California have filed their ninth lawsuit against Merck, taking on the drug company’s dangerous and deceptive Gardasil vaccine, and standing up for innocent young people who have been disabled by the vaccine. The law firm is up against a drug... (Source: NaturalNews.com)
Source: NaturalNews.com - April 29, 2021 Category: Consumer Health News Source Type: news

HPV vaccination in young adults
(JAMA Network)What The Study Did:Survey data were used to estimate the rate of human papillomavirus (HPV) vaccination among young adults ages 18 to 21 in the United States. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 27, 2021 Category: Infectious Diseases Source Type: news

Routine HPV Vaccination for Older Adults May Not Be Cost-Effective
MONDAY, April 5, 2021 -- Extending the age limit for human papillomavirus (HPV) vaccination up to 45 years may not be cost-effective in the United States, according to a study published online March 11 in PLOS Medicine. Jane J. Kim, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2021 Category: Pharmaceuticals Source Type: news

2015 to 2018 Saw Decrease in HPV Infections Among Young Women
FRIDAY, March 26, 2021 -- There have been significant declines in vaccine-type human papillomavirus (HPV) infections among both vaccinated and unvaccinated adolescent girls and young adult women, according to research published in the March 26 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2021 Category: Pharmaceuticals Source Type: news

HPV Infections Are Plummeting Due to Widespread Vaccination
FRIDAY, March 26, 2021 -- Fifteen years of widespread vaccination of U.S. children with the human papillomavirus (HPV) vaccine is reaping big rewards: A more than 80% drop in new infections has been seen in women and girls under the age of 25. That... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 26, 2021 Category: General Medicine Source Type: news

HPV vaccine has led to more than 80% drop in infections, CDC reports
Introduction of the human papillomavirus vaccine in the United States has led to a more than 80% decline in infections nationally since 2003, according to data released Thursday by the CDC. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 25, 2021 Category: Consumer Health News Source Type: news

Call to Eradicate All Types of HPV Cancers, not Just Cervical Call to Eradicate All Types of HPV Cancers, not Just Cervical
Widespread gender-neutral vaccination against human papilloma virus (HPV) would eliminate HPV infections that cause many different cancer types, not just cervical cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
This report describes declines in HPV vaccine-type infection prevalence among females when compared with prevalence before vaccination. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 25, 2021 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news

HPV vaccine not cost-effective for adults age 26 to 45, study finds
Vaccination against human papillomavirus provides limited health benefits for adults aged 26 years and older at a high cost to the healthcare system, according to a study published Thursday by PLOS Medicine. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 11, 2021 Category: Consumer Health News Source Type: news

HPV vaccines for adults over age 26 may not be cost-effective
(Harvard T.H. Chan School of Public Health) Two simulation models suggest that vaccinating adults older than age 26 against human papillomavirus (HPV) would provide limited health benefit, at a substantial cost (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2021 Category: Cancer & Oncology Source Type: news

HPV vaccine may not be cost-effective in adult populations aged over 26 years
This study suggests that HPV vaccination over age 26 years provides limited health benefits at a high cost. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2021 Category: Cancer & Oncology Source Type: news

St. Jude launches program to boost HPV cancer prevention across the globe
(St. Jude Children's Research Hospital) St. Jude is dedicating staff and resources to focus on the prevention of human papillomavirus (HPV)-related cancers around the world through HPV vaccine awareness programming. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2021 Category: Cancer & Oncology Source Type: news

Rwanda: Covid-19 - Pandemic Halts HPV Vaccination in Kigali
[New Times] Several challenges related to the Covid-19 pandemic have frustrated plans to roll out a vaccination programme aimed at eliminating cervical cancer causing Human Papillomavirus (HPV) for girls aged 12, The New Times can exclusively reveal. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 18, 2021 Category: African Health Source Type: news

Parental HPV Vaccine Hesitancy Increased During 2012 to 2018
TUESDAY, Feb. 9, 2021 -- From 2012 to 2018, there was an increase in the proportion of unvaccinated adolescents who received a recommendation for human papillomavirus (HPV) vaccination, but parental HPV vaccine hesitancy also increased, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 9, 2021 Category: Pharmaceuticals Source Type: news

More Parents Balking at Giving Kids Cancer-Fighting HPV Vaccine
TUESDAY, Feb. 9, 2021 -- Although more teens are getting the human papillomavirus (HPV) vaccine, parents'hesitancy is growing, a new study finds. From 2012 to 2018, more doctors recommended their patients get vaccinated with the HPV vaccine --... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 9, 2021 Category: General Medicine Source Type: news

HPV vaccine study shows major geographic disparities in people receiving or completing doses to fight the cancer-causing disease
The human papillomavirus is the most common cause of cervical cancer. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - January 31, 2021 Category: Consumer Health News Authors: Erin Blakemore Source Type: news

Merck's Gardasil vaccine crippled a young man - an ongoing medical tragedy that must be stopped
(Natural News) Robert F. Kennedy Jr. and the Baum Hedlund Law Firm from Los Angeles, California have filed their fifth lawsuit against Merck, taking on the drug company’s dangerous and deceptive Gardasil vaccine, and standing up for innocent young people who have been disabled by the vaccine. The law firm is taking on Merck and... (Source: NaturalNews.com)
Source: NaturalNews.com - January 26, 2021 Category: Consumer Health News Source Type: news

We All Deserve Protection From Covid-19
Credit: United NationsBy Adaora OkoliNEW ORLEANS, US, Dec 11 2020 (IPS) When I contracted Ebola virus disease in August 2014 while working as a medical doctor in a well-known private hospital in Lagos, Nigeria, I was denied access to a potential cure. For 15 days, I battled for my life in a debilitated isolation ward, not knowing if I would survive. But American aid workers who contracted Ebola were administered Zmapp, a monoclonal antibody treatment, which reduces the relative risk of death from Ebola by 40% as well as shorten the duration of stay in the Ebola treatment units. They survived. We were told that Zmapp was e...
Source: IPS Inter Press Service - Health - December 11, 2020 Category: International Medicine & Public Health Authors: Adaora Okoli Tags: Headlines Health TerraViva United Nations Source Type: news

Increasing HPV vaccine uptake in adolescents
(University of Pennsylvania School of Nursing) More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 1, 2020 Category: Cancer & Oncology Source Type: news

Uganda: Uganda Yet to Embrace Hpv Vaccination
[Monitor] he magic bullet to stop the infamous cervical cancer rise, according to experts lies in Human papillomavirus (HPV) vaccination. Countries have since launched several vaccination campaigns as recommended by different world health bodies and specific organisations in the cancer battle. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 23, 2020 Category: African Health Source Type: news

Interventions to Increase HPV Vaccine Coverage Cost-Effective
MONDAY, Nov. 16, 2020 -- Three interventions for increased human papillomavirus (HPV) vaccine coverage are cost-effective, according to a study published online Nov. 16 in Pediatrics. Jennifer C. Spencer, Ph.D., from the Harvard T.H. Chan School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2020 Category: Pharmaceuticals Source Type: news

Black College Students, Especially Women, Delay HPV Vaccination Black College Students, Especially Women, Delay HPV Vaccination
The human papillomavirus (HPV) disproportionately affects people of color and Black gay men, yet many within these communities do not receive the HPV vaccine, most notably college-aged women of color.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 15, 2020 Category: Infectious Diseases Tags: Nursing News Source Type: news

HPV Vaccine Generally Well Tolerated in Males
WEDNESDAY, Nov. 4, 2020 -- Human papillomavirus (HPV) vaccines are safe and well tolerated in males, with few reports of adverse events, according to a study published online Nov. 3 in the British Journal of Clinical Pharmacology. Giulia Bonaldo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 4, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Remains Below Healthy People Goals HPV Vaccination Remains Below Healthy People Goals
Rates of human papillomavirus vaccination increased for both boys and girls in the United States over the past decade but remain below target levels and vary widely among states.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 14, 2020 Category: Infectious Diseases Tags: Pediatrics News Source Type: news

Quality Improvement Coaching for Human Papillomavirus Vaccination Coverage: A Process Evaluation in 3 States, 2018-2019
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - October 8, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Impact of HPV vaccination mandates on social inequalities
(University of California - Riverside) A postdoctoral researcher at the University of California, Riverside, has discovered Human papillomavirus, or HPV, vaccination mandates fall short of ensuring both higher levels of uptake and equal uptake of the vaccine across socioeconomic and racial-ethnic groups. The findings could help facilitate equal access to and compliance with uptake of COVID-19 vaccines, once they are available. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 5, 2020 Category: Infectious Diseases Source Type: news

HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
THURSDAY, Oct. 1, 2020 -- Quadrivalent human papillomavirus (HPV) vaccination of girls and women aged 10 to 30 years is associated with a reduced risk for invasive cervical cancer, according to a study published in the Oct. 1 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 1, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccine Proves Its Mettle Against Cervical Cancer
WEDNESDAY, Sept. 30, 2020 -- Girls who are vaccinated against human papillomavirus (HPV) may drastically cut their chances of developing cervical cancer by age 30, a huge, new study finds. Researchers found that of more than 1.6 million young... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 30, 2020 Category: General Medicine Source Type: news

A Cross-Sectional Survey to Evaluate Potential for Partnering With School Nurses to Promote Human Papillomavirus Vaccination
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - September 24, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Investor Update - September 16, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rates Increasing Among 15-Year-Olds
MONDAY, Sept. 14, 2020 -- From 2011 to 2017, there was an increase in the proportion of U.S. 15-year-olds with at least one-dose or two-dose human papillomavirus (HPV) vaccination, according to a study published online Sept. 14 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rises Among U.S. Kids, But Many Still Unprotected
MONDAY, Sept. 14, 2020 -- More U.S. kids are getting a recommended vaccine that protects against several cancers -- but there is still much room for improvement, a new study finds. At issue is the vaccine against human papillomavirus (HPV). Certain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 14, 2020 Category: General Medicine Source Type: news

HPV vaccination linked to lower risk of precancerous condition
(Wiley) Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 5, 2020 Category: Cancer & Oncology Source Type: news